WEI Yuge, LI Ronghao, SUN Chenyi, ZHU Congmin, CHEN Ting, YANG Hong, LIU Honglei. The Role of Artificial Intelligence in Adverse Drug Reaction Monitoring: Current Status and ChallengesJ. Medical Journal of Peking Union Medical College Hospital, 2025, 16(6): 1363-1370. DOI: 10.12290/xhyxzz.2025-0758
Citation: WEI Yuge, LI Ronghao, SUN Chenyi, ZHU Congmin, CHEN Ting, YANG Hong, LIU Honglei. The Role of Artificial Intelligence in Adverse Drug Reaction Monitoring: Current Status and ChallengesJ. Medical Journal of Peking Union Medical College Hospital, 2025, 16(6): 1363-1370. DOI: 10.12290/xhyxzz.2025-0758

The Role of Artificial Intelligence in Adverse Drug Reaction Monitoring: Current Status and Challenges

  • Adverse drug reactions (ADRs) significantly impact clinical medication safety. The timely identification and prediction of ADRs rely on the efficient analysis of real-world data, such as electronic health records, social media, and spontaneous reporting databases. In recent years, the rapid advancement of artificial intelligence, particularly large language models, in natural language processing, causal reasoning, and complex data mining has provided new technological means for real-time ADRs monitoring and individualized prediction. This paper summarizes the latest research achievements in AI-driven ADRs monitoring. Focusing on diverse data sources, including structured databases and electronic health records, it elaborates on the advantages andchallenges of AI in ADRs event extraction, relationship identification, causal analysis, and risk prediction. The aim is to provide a theoretical reference for constructing more intelligent and efficient ADRs monitoring systems.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return